BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20825473)

  • 1. Plasma total homocysteine and the methylenetetrahydrofolate reductase 677C>T polymorphism do not contribute to the distribution of cervico-cerebral atherosclerosis in ischaemic stroke patients.
    Oh SH; Kim NK; Kim HS; Kim WC; Kim OJ
    Eur J Neurol; 2011 Mar; 18(3):491-6. PubMed ID: 20825473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke.
    Kim OJ; Hong SP; Ahn JY; Hong SH; Hwang TS; Kim SO; Yoo W; Oh D; Kim NK
    Yonsei Med J; 2007 Apr; 48(2):201-9. PubMed ID: 17461517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different impact of hyperhomocysteinemia on cerebral small vessel ischemia and cervico-cerebral atherosclerosis in non-stroke individuals.
    Park SY; An SA; Lee HB; Kim Y; Kim NK; Kim SH; Kim OJ; Oh SH
    Thromb Res; 2013 Jan; 131(1):e12-6. PubMed ID: 23218488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.
    Rassoul F; Richter V; Hentschel B; Geisel J; Herrmann W; Kuntze T
    Indian J Med Res; 2008 Feb; 127(2):154-8. PubMed ID: 18403793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of first stroke in relation to plasma homocysteine and MTHFR 677C>T and 1298A>C genotypes and haplotypes - evidence for an association with hemorrhagic stroke.
    Hultdin J; Van Guelpen B; Winkvist A; Hallmans G; Weinehall L; Stegmayr B; Nilsson TK
    Clin Chem Lab Med; 2011 Sep; 49(9):1555-62. PubMed ID: 21631392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine, small-vessel disease, and atherosclerosis: an MRI study of 825 stroke patients.
    Jeon SB; Kang DW; Kim JS; Kwon SU
    Neurology; 2014 Aug; 83(8):695-701. PubMed ID: 25031284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction.
    Rallidis LS; Gialeraki A; Komporozos C; Vavoulis P; Pavlakis G; Travlou A; Lekakis I; Kremastinos DT
    Atherosclerosis; 2008 Sep; 200(1):115-20. PubMed ID: 18255072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia.
    Pisciotta L; Cortese C; Gnasso A; Liberatoscioli L; Pastore A; Mannucci L; Irace C; Federici G; Bertolini S
    Atherosclerosis; 2005 Apr; 179(2):333-8. PubMed ID: 15777550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
    Tylicki L; Födinger M; Puttinger H; Rutkowski P; Strozecki P; Tyszko S; Rutkowski B; Hörl WH
    Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Rontu R; Kähönen M; Hutri-Kähönen N; Rönnemaa T; Marniemi J; Viikari JS; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(1):22-30. PubMed ID: 17934972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and the methylenetetrahydrofolate reductase 677C-->T polymorphism in relation to muscle mass and strength, physical performance and postural sway.
    Swart KM; Enneman AW; van Wijngaarden JP; van Dijk SC; Brouwer-Brolsma EM; Ham AC; Dhonukshe-Rutten RA; van der Velde N; Brug J; van Meurs JB; de Groot LC; Uitterlinden AG; Lips P; van Schoor NM
    Eur J Clin Nutr; 2013 Jul; 67(7):743-8. PubMed ID: 23695205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis.
    Fujimaki C; Hayashi H; Tsuboi S; Matsuyama T; Kosuge K; Yamada H; Inoue K; Itoh K
    Biomarkers; 2009 Feb; 14(1):49-54. PubMed ID: 19283524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking.
    Semmler A; Moskau S; Stoffel-Wagner B; Weller M; Linnebank M
    Clin Invest Med; 2009 Dec; 32(6):E310. PubMed ID: 20003837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke.
    Al-Allawi NA; Avo AS; Jubrael JM
    Neurol India; 2009; 57(5):631-5. PubMed ID: 19934565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents.
    Böttiger AK; Hurtig-Wennlöf A; Sjöström M; Yngve A; Nilsson TK
    Int J Mol Med; 2007 Apr; 19(4):659-65. PubMed ID: 17334642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The maternal homocysteine pathway is influenced by riboflavin intake and MTHFR polymorphisms without affecting the risk of orofacial clefts in the offspring.
    Vujkovic M; Steegers EA; van Meurs J; Yazdanpanah N; van Rooij IA; Uitterlinden AG; Steegers-Theunissen RP
    Eur J Clin Nutr; 2010 Mar; 64(3):266-73. PubMed ID: 19935819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.